# Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rosiglitazone-decreases-peroxisome-proliferator-receptor-gamma-levels-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anna R. Carta,Lucia Frau,Augusta Pisanu,Jadwiga Wardas,Saturnino Spiga,Ezio Carboni |
| Citations | 134 |
| DOI | 10.1016/j.neuroscience.2011.07.046 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2014941838 |
| PMID | 21839812 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Saturnino Spiga](https://scholariq.org/researchers/saturnino-spiga/)

## Paper journal

- [Neuroscience](https://scholariq.org/journals/neuroscience/)

## Paper primary topic

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)

## Paper topics

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.